Patent Protection

Vivesto maintains a robust patent protection strategy for XR-17™-formulated drugs, independent of the API used.

In addition to technical patents, Vivesto employs an aggressive IP strategy for its immaterial rights across jurisdictions around the world.

Family name Scope summary
Water-insoluble Water-insoluble active substance formulated with XR-17
XR-17 process Improved process for the preparation of XR-17 component XMeNa
XR-17 process 2 A further improved process for the preparation of XR-17 component XMeNa
XR-18 XR-18 compounds and their use in drug formulation

This summary provides an overview of the Drug Delivery Portfolio. Detailed information on granted patents and published applications is available from official patent authorities.